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Abstract
The application of desymmetrization strategies in chemical synthesis has allowed fundamentally 
new synthetic sequences that efficiently create dense and polyfunctional stereochemical arrays. 
Enantiotopic group discrimination has become a well-established method of global 
desymmetrization, while the conceptually unique strategy of local desymmetrization by 
diastereotopic group discrimination has its own advantages. This microreview focuses on the 
application of local desymmetrization in natural product synthesis and places a particular 
emphasis on the efficiency engendered by diastereotopic group discrimination. Local 
desymmetrization is subdivided into three distinct manifolds; examples under each paradigm are 
presented and compared.
Graphical abstract
Three distinct modes of diastereotopic group selection in natural product synthesis are reviewed. 
Case studies that enable the rapid buildup of stereochemical complexity using local 
desymmetrization are emphasized.
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1. Introduction
The abundance of stereochemically rich molecules in natural products and drug molecules 
presents a plethora of synthetic challenges that can be attacked from many angles. The 
toolbox that synthetic organic chemists have at their disposal has evolved to provide 
reactions that efficiently construct stereochemical arrays. Of the myriad strategies available 
for stereoselective natural product synthesis, desymmetrization methods possess key 
advantages and simultaneously face unique challenges[1] Stereoselective desymmetrization 
as a synthetic tactic can be dissected into enantiotopic group discrimination (differentiation 
of enantiotopic groups in achiral molecules), and diastereotopic group discrimination. While 
global desymmetrization strategies that make use of enantiotopic group discrimination have 
been well studied and reviewed,[1] local desymmetrization strategies that apply 
diastereotopic group discrimination have received substantially less attention, despite their 
ability to input multiple stereocenters with high fidelity.[2]
The application of local desymmetrization as a strategy for the rapid construction of 
stereochemical complexity has been most evident in the field of natural product synthesis. 
The value afforded by this strategy is derived from its efficiency, which is a consequence of 
the multipurpose nature of diastereotopic group discrimination. For example, using this 
strategic manifold, it is possible to use achiral reagents/catalysts to carry out functional 
group manipulations while simultaneously controlling the outcome at a nascent stereocenter 
(Figure 1, i). Expanding on that theme, it is possible to introduce additional stereocenters if 
the diastereotopic groups are themselves prochiral (Figure 1, ii). If the diastereotopic group 
selection is occurring concomitantly with conversion of a chirotopic non-stereocenter into a 
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stereocenter, then 1-2 stereocenters can be defined (Figure 1, iii). Cases (ii) and (iii) in 
particular offer possibilities for especially dramatic increases in stereochemical complexity. 
Desymmetrization tactics can become truly enabling in instances where it is markedly 
simpler to synthesize a symmetrical substrate (or fragment of a substrate) and apply 
desymmetrization methods than it is to construct the same motifs using pre-installed 
chirality. This microreview will focus on these themes, and specifically on cases where 
diastereotopic group discrimination (local desymmetrization) has successfully been applied 
to total synthesis. The microreview covers cases after 2010, with the inclusion of one earlier 
foundational example. Our aim is not to be comprehensive, but instead to provide the reader 
with the range of the current art.
2. Simple Diastereotopic Group Selection
A. Koert's Synthesis of Awajanomycin (2011)
In 2011, the Koert group completed a total synthesis of (+)-awajanomycin (4) (Scheme 1).[3] 
The authors were able to synthesize enantioenriched alkene 1 rapidly from diethyl 
ketomalonate using an asymmetric allylboration. The diester 1 was treated with potassium 
osmate dihydrate to accomplish a substrate-controlled dihydroxylation; the authors 
attributed the stereochemical outcome of the dihydroxylation to the conformational bias 
enforced by the TMS group. The resulting diol (2) underwent a diastereotopic group 
discrimination via lactonization to form 3. By distinguishing the two ethyl esters, the authors 
were able to control the outcome at the new stereocenter defined during the lactonization. In 
addition to the requisite diasterotopic group selection, this case successfully navigates a 
potentially complicating constitutional isomer issue: the formation of a single γ -lactone 
occurs to the complete exclusion of alternative δ-lactones. By differentiating the diols during 
the diastereotopic group selection, the remaining alcohol could be functionalized in a 
manner that permitted the lactone intermediate 3 to be advanced through five additional 
synthetic steps to complete the total synthesis of (+)-awajanomycin (4).
B. Wu's Synthesis of 2-epidevinylantirhine, geissoschizol, isogeissoschizol, and 
dihydrocorynantheol (2013)
In 2013, the Wu group realized a catalytic asymmetric transfer hydrogenation/lactamization 
cascade that delivers the core of several indoloquinolizidine natural products (Scheme 2).[4] 
The initial asymmetric reduction of the imine moiety of 5 to 6 rendered the ethyl esters 
diastereotopic. Diastereoselection is realized in stage two of the cascade by virtue of the fact 
that the favored and disfavored six-membered transition states place the C2 substituent in an 
equatorial or axial position, respectively. The locally desymmetrizing lactamization is 
spontaneous after the enantioselective reduction, delivering two new stereocenters in one 
step. The approach is conceptually similar to the example from Koert above, which also 
utilized local desymmetrization of a diester. Reduction of the resulting amide 7 with LiAlH4 
delivered 2-epidevinylantirhine (8) in 84% yield. Using this reaction manifold to efficiently 
access 7, the authors were also able to complete the total syntheses of geissoschizol (9), 
isogeissoschizol (10), and dihydrocorynantheol (11).
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C. Sorensen's Synthesis of Jiadifenolide (2014)
The relative inertness of simple methyl groups renders them a priori as unlikely candidates 
for diastereotopic group selection; however, the advent of modern C–H activation 
methodologies has revealed opportunities for the generation of quaternary stereocenters by 
differentiation of gem-dimethyl groups. During their synthesis of jiadifenolide (14), the 
Sorensen group arrived at intermediate 12.[5] Their synthetic approach to fashion the all-
carbon quaternary center at C5 was to use diastereotopic group discrimination (Scheme 3). 
By utilizing a C–H activation protocol developed by Sanford and coworkers,[6] they were 
able to achieve directed oxidation of the unactivated diastereotopic methyl groups at C5. 
Sanford's Pd(II)/PhI(OAc)2 conditions led to a 1:1 mixture of diastereomeric acetates (13a 
and 13b), presumably due to the equilibrating chair conformations (12a and 12b) that are 
similar in their stability and reactivity (Scheme 3), a circumstance that would lead to poor 
differentiation. While the observed selectivity was not optimal, the reaction fortunately did 
furnish separable diastereomers. The authors were then able to carry acetate 13b through 
eight synthetic steps to arrive at the target molecule (14).
D. Johnson's Synthesis of Paspaline (2015)
In 2015, the Johnson group described a total synthesis of the indole diterpenoid paspaline 
(17) which merged local and global desymmetrization strategies (Scheme 4).[7] In the course 
of the synthesis, intermediate 15 was synthesized by a route that took advantage of 
enantiotopic group discrimination via a biocatalytic reduction. Moving forward from 15, 
application of the Sanford C–H activation[6] allowed the completely diastereselective 
acetoxylation of the equatorial methyl group to give 16. In contrast to the jiadifenolide case, 
the tricycle 15 is a rigid system that places the diastereotopic methyl groups in very different 
environments in relation to the oxime directing group. The equatorial methyl group is 
approximately coplanar with the benzyl oxime, a circumstance that led to perfect 
diastereocontrol for the C–H acetoxylation. This local desymmetrization enabled the 
stereochemical outcome at an all-carbon quaternary center to be governed. This route was 
not “plan A” and the application of the local symmetry-breaking C–H functionalization in 
this synthesis averted a crisis by allowing a rather non-intuitive disconnection. Acetate 16 
was then carried on to complete the total synthesis of paspaline (17).
E. Porco's Synthesis of (-)-6-epi- and (+)-30-epi-13,14-Didehydroxyisogarcinol (2016)
The Porco group recently reported a synthesis of four polycyclic polyprenylated 
acylphloroglucinol (PPAP) targets, two of which required the use of diastereotopic group 
differentiation (Scheme 5).[8a] Through a regioselective bis-alkylation of a phenol, the 
authors were able to synthesize polyene (+)-(S,S)-18. When exposed to SnCl4 and diphenyl 
phosphoric acid, the bicyclic pyran 19 was obtained in 47% yield and 10:1 dr. Interestingly, 
when they treated the same acylphloroglucinol starting material with BF3 and p-TsOH, the 
diastereomeric product 20 was obtained in 42% yield and 5:1 dr. It was proposed that the 
Lewis acid binds in a bidentate manner to the β-keto enol, resulting in a hexacoordinate Sn- 
or tetrahedral BF2 complex, depending on the reagent used.[8b-d] They argued, using B3LYP 
calculations comparing relative transition state energies, that the diastereoselectivity in these 
reactions arises from an intramolecular protonation event after complex formation. The 
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authors went on to use 19 to complete the synthesis of (-)-6-epi-13,14-
didehydroxyisogarcinol (21) and 20 to complete the synthesis of (+)-30-epi-13,14-
didehydroxyisogarcinol (22) using the same three-step sequence.
3. Diastereotopic Group Selection with π -Face Selective Addition
A. Leighton's Synthesis of Zincophorin Methyl Ester (2011)
In 2011, Leighton and coworkers reported a convergent and stereoselective synthesis of 
zincophorin methyl ester (28) (Scheme 6).[9] Using Shi's asymmetric epoxidation,[10] 
Pagenkopf's epoxide-opening alkynylation,[11] and a NaH-promoted dehydrogenative 
silylation, the authors assembled the key substrate 23. The authors were then able to use 
Rh(acac)CO2 with 1000 psi CO to trigger a silylformylation-crotylsilylation cascade 
followed by a Tamao-Fleming oxidation and a diastereoselective tautomerization. The 
diastereotopic group discrimination in this case occurs during the crotylsilylation, where the 
crotyl groups were successfully distinguished. Based on an earlier model proposed by the 
same group,[9c] it feasible that attack of the crotyl group from the Si face of the aldehyde (as 
in 25b) would be disfavored compared to attack from the Re face (as in 25a) due to steric 
clashing with the C12 methyl group. In prior work,[9d] the authors described the enol 
intermediate formed by crotylsilylation and Tamao-Fleming oxidation to be 
conformationally controlled by A[1,3] strain and syn-pentane interactions; they argued that 
both secondary alcohols were able to participate in hydrogen bonding to allow delivery of a 
proton to the back face of the enol. The final product of this cascade, ketone 27, was 
obtained in ≥15:1 dr in a reaction sequence that rapidly provides five new contiguous 
stereocenters from a simple starting material. Ketone 27 was carried on and used to 
complete the total synthesis of zincophorin methyl ester (28). This sequence represents an 
unusual case where the three stereocenters that are established during the diastereotopic 
group selection do not all correspond to the three new stereocenters that appear in the final 
product. The silicon atom becomes stereogenic upon intramolecular crotylation but is lost 
during the Tamao-Fleming oxidation/diastereoselective tautomerization sequence that 
provides the third stereocenter (ketone α-center) in the final product. Thus, diastereotopic 
group selection in this case is leveraged exclusively to provide mutual π-facial selectivity in 
two distal prochiral functional groups.
B. Willis's Synthesis of Blepharocalyxin D (2013)
In 2013, the Willis group reported a total synthesis of (−)-blepharocalyxin D (33) (Scheme 
7).[12] Using (S)-homoallylic alcohol 29, the authors were able to synthesize the 
desymmetrization substrate 30, which possesses diastereotopic styrenyl groups. The authors 
found that treating diene 30 with acetal 31 and TMSOTf led to the bicyclic lactone 32 
completely diastereoselectively. Three additional steps led to the completion of the 
synthesis.
The authors explained their high diastereoselectivity in the transformation from 30 to 32 
using a chair model for the transition state geometry (Scheme 8). They argued that, 
following oxocarbenium ion formation from the two reaction components to give 34, the 
lowest-energy reaction path would require the substituent at C5 to be equatorial. Subsequent 
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trapping of the nascent benzylic carbenium ion (in 35) by the ester would then furnish 
lactone 32.
C. Zakarian's Synthesis of Tatanans B and C (2013)
Zakarian's approach to the synthesis of tatanans B (39) and C (40) takes advantage of 
diastereotopic group differentiation during a cyclodearomatization (Scheme 9).[13] α, β-
Unsaturated ester 36 was used as a starting point to synthesize the desymmetrization 
substrate 37. Then, the allylic carbonate was converted into a palladium π-allyl species, 
which was found to undergo an intramolecular cyclodearomatization to give 
spirocyclohexadienone 38 in 84% yield as a mixture of diastereomers (it should be noted 
that one of these diastereomers arises from atropoisomerism). This reaction quickly allowed 
tatanans B (39) and C (40) to be completed after two additional steps.
The authors rationalized the stereochemical outcome of the reaction using four transition 
state-based arguments (Scheme 10). First, they argued that TS-41a is more favorable than 
TS-41b due to the steric clashing that would occur in the latter, between the β-methoxy 
substituent of the cyclohexadienone and the nearby aryl ring. By comparing TS-42a and 
TS-42b, they were able to explain which diastereotopic aryl group undergoes the 
cyclodearomatization; they pointed out that the axial positioning of the aryl group in TS-42b 
is likely to be disfavored compared to the equatorial position in TS-42a. The next pair of 
transition states, TS-43a and TS-43b, compare an attack on an equatorial π-allyl 
electrophile with an axial one; the former was predicted to be favored. Finally, with respect 
to the atropodiastereomeric structures TS-44a and TS-44b, the authors proposed that there 
would be a noticeable steric interaction occurring if the ortho-OMe group forced into the 
proximity of the fledgling cyclohexane ring. In this example, both the reactive functional 
group that is breaking symmetry and the π-faces of the diastereotopic groups are prochiral; 
therefore, three new stereogenic centers arise in the symmetry breaking event.
D. Johnson's Synthesis of Pactamycin (2013)
In 2013, Johnson and coworkers disclosed a successful total synthesis of pactamycin 
(Scheme 11).[14b, 14c] This approach used 2,4-pentanedione-derived urea 45 in an 
enantioselective Mannich reaction with imine diene 46, which provided 47 in 70% yield and 
98:2 er. A diastereoselective reduction using Li(OtBu)3AlH (LTBA) afforded the secondary 
alcohol 49 with three contiguous stereocenters in 72% yield. The stereochemical model (48) 
that we proposed for the hydride addition invoked chelation[15] of the lithium to the 
carbamate nitrogen as well as the carbonyl of the ketone that is undergoing the reduction. In 
this way, the stereochemical information from the Mannich addition was parlayed in a 
diastereotopic group differentiation, and 47 was locally desymmetrized. This is a good 
example of how prochiral diastereotopic groups can be differentiated in order to generate 
two new adjacent stereocenters. Keto alcohol 49 was then elaborated into pactamycin (50) in 
eleven steps. The brevity of this approach facilitated creation of a library of pactamycin 
analogs and assessment of their biological activity in cancer cell lines.[14d]
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E. Shair's Synthesis of Hyperforin, Nemorosone, and Secohyperforin (2013, 2015)
In 2013, the Shair group disclosed an asymmetric total synthesis of the PPAP natural 
product hyperforin (53) (Scheme 12).[16] The crux of their synthetic strategy was to 
differentiate diastereotopic enol ethers to define an all-carbon quaternary center. The group 
developed a two-step synthesis of the local desymmetrization substrate 51 from simple 
starting materials. Their intention was to use a Lewis acid to activate the epoxide in 51 and 
allow a nucleophilic attack by an enol ether to form an oxonium intermediate (55). 
Subsequent intramolecular attack by the nascent secondary alkoxide would then form a 
cyclic ketal (Scheme 13). By screening Lewis acids that were capable of engaging the 
epoxide in 51, TMSOTf was identified as the optimal Lewis acid, providing the desired 
tricyclic product in 79% yield. The authors were then able to use desymmetrized 
intermediate 52 to finish the total synthesis of hyperforin (53) after ten additional steps.
Their stereochemical outcome of the Lewis acid-mediated epoxide opening cascade was 
consistent with the chairlike transition state (54b). Epoxide-opening by the alternative enol 
ether would require a boatlike transition state (54a), which was suggested to be less 
favorable. Their approach also imposed sufficient geometric constraints to favor 6-endo-tet 
cyclization (at the more substituted epoxide carbon) over the potentially competitive 5-exo-
tet mode.
After completing their synthesis of hyperforin (53), the Shair group went on to apply their 
local desymmetrization approach to two other PPAP natural products: nemorosone (58) and 
secohyperforin (59) (Scheme 14).[17] In a departure from their approach to hyperforin (53), 
the authors sought to eliminate the need for a C-O bond cleavage step (primarily due to the 
use of Me2BBr in that step). With that goal in mind, the authors developed conditions to 
prevent the type of ring closure (55 → 52) that led to cyclic ketal 52 in the hyperforin 
synthesis. It was found that TIPSOTf and 2,6-lutidine in DCM, warming from -78 °C to 
room temperature, gave a 95% yield of the TIPS-protected secondary alcohol resulting from 
epoxide opening (57). This intermediate (57) was converted into a common intermediate 
which the authors used to access both target molecules. They were able to install a benzoyl 
(in the case of nemorosone (58)) or an isobutyryl (in the case of secohyperforin (59)) group 
at the bridgehead by deprotonating with LiTMP and trapping with the desired acyl chloride. 
This strategy allowed the authors to expand the desymmetrization motif used for hyperforin 
and enabled the total synthesis of both targets.
4. Diastereotopic Group Selection and Configurational Definition of a 
Chirotopic Non-stereogenic Group
A. Schreiber's Synthesis of FK506 (1990)
An early example of local desymmetrization comes from Schreiber and coworkers, who 
applied a diastereoselective discrimination of two terminal methyl esters in the synthesis of 
the FKBP-binding agent FK506 (62) (Scheme 15).[18] The authors synthesized the pseudo-
C2-symmetric substrate 60 from arabitol through a nine-step sequence. Treatment of 60 with 
Pd(OH)2 unveiled the chirotopic non-stereogenic free alcohol, which the authors used in a 
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diastereoselective intramolecular lactonization (dr not reported) with pyridinium p-
toluenesulfonate (PPTS) to arrive at 61.
Using ground-state conformational analysis similar to that of Hoye,[19] the stereochemical 
outcome of this desymmetrization can be analyzed by considering the relative populations of 
63a and 63b at equilibrium (Scheme 16). Considering the quasi 1,3-diaxial interactions 
present in 63b, the equilibrium likely lies to the right, providing a plausible explanation for 
the preferential lactonization that gives 61. The benefits that the local desymmetrization 
strategy offered in this context were control of the incipient fifth stereocenter in 61, as well 
as differentiation of the terminal methyl esters. The authors were then able to use 61 to 
construct the C10-C19 domain of FK506 (62).
B. Sammakia's Synthesis of Dermostatin A (2011)
The oxopolyene macrolide dermostatin A (66) was synthesized by the Sammakia group 
using an early local desymmetrization of 64 (Scheme 17).[20] The authors found that 
subjecting 64 to PPTS in toluene at 110 °C allowed a trans-ketalization to give 65 with 
perfect diastereoselectivity. Although they observed a 9:1 mixture of internal acetal to 
terminal acetal, they were able to isolate 65a in 82% yield.
The authors rationalized their impressive stereoselectivity using the ground-state 
conformations of 65a and 65b (Scheme 18). They argued that the axial substituent present in 
65b makes it less thermodynamically stable than 65a, which results in a population 
imbalance favoring the formation of 65a at thermodynamic equilibrium. Additionally, they 
emphasized the elevated impact of the A-value in 1,3-dioxanes compared to 
cyclohexanes.[21] By taking advantage of the relative stability of 65a, the authors were able 
to set a stereocenter and differentiate the termini. Using 65a to form the polyol core of the 
final product, the authors completed the total synthesis of dermostatin A (66).
C. Krische's Synthesis of Zincophorin Methyl Ester (2015)
The Krische group employed a distinct diastereotopic group selection in their synthesis of 
zincophorin methyl ester (28). The key building block was prepared through hydrogen 
borrowing catalysis (Scheme 19).[22] Using the simple, cheap, achiral starting material 67, 
the authors were able to use an (S)-Ir-SEGPHOS complex to catalyze a double anti-
crotylation with 3-butenyl-2-acetate to give 68. From that point, an iodoetherification 
allowed a diastereotopic discrimination between the two terminal alkenes to provide 69a in 
high yield and stereoselectivity, forming a “propionate based triketide motif”.[22] Using an 
analysis of the conformer equilibrium between 70a and 70b, we can understand that 
prohibitively strong 1,3-diaxial interactions arise when the 1-buten-3-yl group is placed in 
the axial position, which results in the observed diastereomer (Scheme 20). This reaction 
sequence installed six contiguous stereocenters in only two synthetic operations. The 
iodopyran 69a served to temporarily protect one alkene so that the other olefinic terminus 
could be homologated via a cross metathesis reaction; reductive fragmentation immediately 
after the metathesis restored the alkene and alcohol functionality for ultimate elaboration to 
zincophorin methyl ester (28).
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5. Outlook and Conclusions
The application of desymmetrization strategies to natural product synthesis continues to 
have a positive impact on the field in terms the efficiency with which difficult 
stereochemical patterns can be constructed. While enantiotopic group discrimination (global 
desymmetrization) remains a cornerstone for synthetic chemists seeking to control absolute 
stereochemistry, diastereotopic group discrimination (local desymmetrization) continues to 
evolve as a tactic that has its own benefits: 1) achiral reagents can be used to control the 
stereochemical outcome at prostereogenic carbons, 2) there is the realistic possibility of 
separating the products of the desymmetrization (which typically more challenging if the 
products are enantiomers, as in enantiotopic differentiation), and 3) if diastereotopic groups 
can be considered differentiable, it can greatly simplify retrosynthetic analysis of complex 
targets. For these reasons, we envisage that diastereotopic group differentiation will continue 
to have a burgeoning role in asymmetric synthesis and will find new applications in the field 
going forward.
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Figure 1. 
Complexity-building local desymmetrization modes enabled by diastereotopic group 
discrimination.
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Scheme 1. 
Total synthesis of awajanomycin by Koert.
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Scheme 2. 
Total synthesis of 2-epivinylantirhine, geissoschizol, isogeissoschizol, and 
dihydrocorynantheol.
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Scheme 3. 
Total synthesis of jiadifenolide by Sorensen.
Horwitz and Johnson Page 15
European J Org Chem. Author manuscript; available in PMC 2018 March 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Scheme 4. 
Total synthesis of paspaline by Johnson.
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Scheme 5. 
Porco's synthesis of two PPAP targets.
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Scheme 6. 
Total synthesis of zincophorin methyl ester by Leighton.
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Scheme 7. 
Total synthesis of (-)-blepharocalyxin D by Willis.
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Scheme 8. 
Rationale for observed diasteroetopic group differentiation.
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Scheme 9. 
Total synthesis of tatanans B and C by Zakarian.
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Scheme 10. 
Transition state comparisions for cyclodearomatization.
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Scheme 11. 
Total synthesis of pactamycin by Johnson.
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Scheme 12. 
Total synthesis of hyperforin by Shair.
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Scheme 13. 
Stereochemical model for Lewis acid-mediated desymmetrization.
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Scheme 14. 
Total synthesis of nemorosone and secohyperforin by Shair.
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Scheme 15. 
Total synthesis of FK506 by Schreiber.
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Scheme 16. 
Conformational equilibrium leading to the observed lactonization.
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Scheme 17. 
Total synthesis of dermostatin A by Sammakia.
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Scheme 18. 
Total synthesis of dermostatin A by Sammakia.
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Scheme 19. 
Total synthesis of zincophorin methyl ester by Krische.
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Scheme 20. 
Rationalization of stereochemical outcome in iodoetherification.
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